Skip to main content

Table 2 Patient characteristics

From: Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiences

Patient identification number

Gender

Country of birth

Age

Highest level of education

Cancer Diagnosis

CVD Diagnosis

Number clinic visits

1

M

Australia

65

Lower secondary

Metastatic lung

Chronic AF

HT

Dyslipidemia

5

2

M

Australia

73

Lower secondary

Metastatic

Melanoma

MVR & Atrial septal defect repair 2019

Heart Failure

9

3

F

Australia

61

Bachelor degree

Breast

HT

Morbid obesity

10

4

F

Australia

47

High School Certificate

Breast

LVEF drop

6

5

M

Australia

57

Certificate

Melanoma metastatic

ACS

HT

LVH due to HT

4

6

F

Australia

49

Certificate

Metastatic breast

HT

Left ventricular systolic dysfunction

2

7

F

Australia

64

Upper secondary

Sigmoid

Metastatic breast

Minor CAD

2

8

M

United Kingdom

62

PhD

AL Amyloidosis

LVH

4

9

F

Australia

64

Bachelor degree

Breast

PHT

PAF

5

10

F

New Zealand

43

Upper secondary

Breast

Ex smoker

Overweight

PCOS

2

11

F

Australia

38

Bachelor degree

Breast

Ex-smoker

2

12

F

Australia

63

Lower secondary

Follicular NHL

HFrEF

8

13

M

Australia

74

Bachelor degree

Metastatic clear cell, renal cell

MVR

DCM

AF

13

14

F

Australia

59

Certificate

Breast

HT

Dyslipidemia

NSTEMI

7

15

F

Australia

62

Yr 10

Breast

Dyslipidemia

Osteoarthritis

6

  1. AF Atrial Fibrillation, CAD Coronary artery disease, CVD Cardio-vascular disease, DCM Dilated cardiomyopathy, HFrEF Heart failure with preserved ejection fraction, HT Hypertension, LVEF Left ventricular ejection fraction, LVH Left ventricular hypertrophy, MVR Mitral Valve Regurgitation, NSTEMI Non-ST-Elevation Myocardial Infarction, PAF Paroxysmal atrial fibrillation, PCOS Polycystic ovary syndrome, PAF Paroxysmal atrial fibrillation, PHT Pulmonary hypertension